spacer
home > > autumn 2018 > clinical service
PUBLICATIONS


Clinical Service

With the NHS currently facing some of its greatest challenges in a 70-year history, clinical trials for new treatments and technologies could provide the solutions to seemingly insurmountable problems: endless surgery waiting lists, bed-blocking, and clinicians and nurses stretched to their limit. Do public-private partnerships between the NHS and medical technology developers hold the key?

Successful outcomes in device development and the development of clinical and health economic benefits rely heavily on the strong partnerships between clinicians and med-tech developers, with both parties committed to improving outcomes for patients. The clinicians that embrace innovation and that are forward-thinking must be championed. Collaborating with those willing to invest in and introduce evidence-based therapies to simplify treatments will help build a more robust health system that is moving forward, rather than stuck in its tracks under strain.

2018 marks the NHS’s 70th birthday, and, as the British institution celebrates 70 years of service, the general public rushed to express their gratitude; from cradle to grave, the NHS is hailed for its care for every citizen, no matter their condition, circumstance, or means.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Bernard Ross is the CEO at Sky Medical Technology, a UK-based medical devices company. Bernard and the company develop a range of products tailored to the needs of different medical application areas, selling both directly and through strategic partnerships or distributors in each major clinical area. Clinical areas of interest include reduction of oedema, prevention of venous thromboembolism, wound healing, and elite sport recovery.
spacer
Bernard Ross
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sense Accelerates Instrument-Free Molecular Diagnostic Test for COVID-19

April 1, 2020 – Sense Biodetection Limited (Sense) has today announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.
More info >>

White Papers
 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement